Atlas Trials

Chengdu CoenBiotech Co., Ltd

5 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Chengdu CoenBiotech Co., Ltd

RecordFirmDate
Clinical Trial to Evaluate the Efficacy and Safety of EEC for the Diagnosis of Mycobacterium Tuberculosis Infection in People Aged 3 Years and Above (NCT07152639)Chengdu CoenBiotech Co., Ltd2025-08-09
Clinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoperative Recurrence of Medium/High-risk Non-muscle Invasive Bladder Cancer (NMIBC) (NCT06241755)Chengdu CoenBiotech Co., Ltd2023-12-28
Clinical Trial to Explore the Skin Test Dosage of EEC in People Aged 18 to 65 Years Old and the Safety and Preliminary Efficacy in People Aged 3 to 75 Years Old. (NCT06305104)Chengdu CoenBiotech Co., Ltd2023-07-18
Phase I Clinical Trial to Evaluate the Safety of Recombinant Mycobacterium Tuberculosis Fusion Protein (EEC) in Healthy Adults Aged 18-65 and Patients With Pulmonary Tuberculosis (NCT06224608)Chengdu CoenBiotech Co., Ltd2023-01-17
Clinical Study to Investigate the Safety and Tolerance of Therapeutic BCG in Postoperative Adjuvant Therapy in Subjects With Moderate to High-risk Non-muscular Invasive Bladder Cancer (NMIBC) (NCT06350838)Chengdu CoenBiotech Co., Ltd2022-11-11

Track Chengdu CoenBiotech Co., Ltd automatically

Every clearance here is in the API, with alerts when new ones post.